These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


207 related items for PubMed ID: 36459833

  • 21. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
    Lin F, Zhang G, Yang X, Wang M, Wang R, Wan M, Wang J, Wu B, Yan T, Jia Y.
    J Ethnopharmacol; 2023 Mar 01; 303():115933. PubMed ID: 36403742
    [Abstract] [Full Text] [Related]

  • 22. MYSM1 inhibits human colorectal cancer tumorigenesis by activating miR-200 family members/CDH1 and blocking PI3K/AKT signaling.
    Chen X, Wang W, Li Y, Huo Y, Zhang H, Feng F, Xi W, Zhang T, Gao J, Yang F, Chen S, Yang A, Wang T.
    J Exp Clin Cancer Res; 2021 Oct 27; 40(1):341. PubMed ID: 34706761
    [Abstract] [Full Text] [Related]

  • 23. Overexpression of ribonuclease inhibitor defines good prognosis and suppresses proliferation and metastasis in human colorectal cancer cells via PI3K/AKT pathway.
    Tang Y, Liu P, Tian Y, Xu Y, Ren F, Cui X, Fan J.
    Clin Transl Oncol; 2015 Apr 27; 17(4):306-13. PubMed ID: 25257839
    [Abstract] [Full Text] [Related]

  • 24. MOR promotes epithelial-mesenchymal transition and proliferation via PI3K/AKT signaling pathway in human colorectal cancer.
    Gao L, Yang L, He Y, Liu Y, Xu P, Zhang J, Dai S, Luo X, Sun Z.
    Acta Biochim Biophys Sin (Shanghai); 2022 Aug 25; 55(1):72-80. PubMed ID: 35983971
    [Abstract] [Full Text] [Related]

  • 25. BCL6B suppresses proliferation and migration of colorectal carcinoma cells through inhibition of the PI3K/AKT signaling pathway.
    Gu Y, Li A, Sun H, Li X, Zha H, Zhao J, Xie J, Zeng Z, Zhou L.
    Int J Mol Med; 2018 May 25; 41(5):2660-2668. PubMed ID: 29393377
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Up-regulation of microRNA-302a inhibited the proliferation and invasion of colorectal cancer cells by regulation of the MAPK and PI3K/Akt signaling pathways.
    Wei ZJ, Tao ML, Zhang W, Han GD, Zhu ZC, Miao ZG, Li JY, Qiao ZB.
    Int J Clin Exp Pathol; 2015 May 25; 8(5):4481-91. PubMed ID: 26191138
    [Abstract] [Full Text] [Related]

  • 29. TGM3 functions as a tumor suppressor by repressing epithelial‑to‑mesenchymal transition and the PI3K/AKT signaling pathway in colorectal cancer.
    Feng Y, Ji D, Huang Y, Ji B, Zhang Y, Li J, Peng W, Zhang C, Zhang D, Sun Y, Xu Z.
    Oncol Rep; 2020 Mar 25; 43(3):864-876. PubMed ID: 32020212
    [Abstract] [Full Text] [Related]

  • 30. GPR56 promotes proliferation of colorectal cancer cells and enhances metastasis via epithelial‑mesenchymal transition through PI3K/AKT signaling activation.
    Ji B, Feng Y, Sun Y, Ji D, Qian W, Zhang Z, Wang Q, Zhang Y, Zhang C, Sun Y.
    Oncol Rep; 2018 Oct 25; 40(4):1885-1896. PubMed ID: 30066935
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. RING finger protein 128 (RNF128) regulates malignant biological behaviors of colorectal cancer cells via PI3K/AKT signaling pathway.
    Zhuang Y, Liu PF, Zhan Y, Kong DL, Tian F, Zhao P.
    Cell Biol Int; 2022 Oct 25; 46(10):1604-1611. PubMed ID: 35723244
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Restoration of miR-152 expression suppresses cell proliferation, survival, and migration through inhibition of AKT-ERK pathway in colorectal cancer.
    Ghazanchaei A, Mansoori B, Mohammadi A, Biglari A, Baradaran B.
    J Cell Physiol; 2018 Jan 25; 234(1):769-776. PubMed ID: 30076720
    [Abstract] [Full Text] [Related]

  • 36. Andrographolide enhanced radiosensitivity by downregulating glycolysis via the inhibition of the PI3K-Akt-mTOR signaling pathway in HCT116 colorectal cancer cells.
    Li X, Tian R, Liu L, Wang L, He D, Cao K, Ma JK, Huang C.
    J Int Med Res; 2020 Aug 25; 48(8):300060520946169. PubMed ID: 32787737
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. DEPDC1B is involved in the proliferation, metastasis, cell cycle arrest and apoptosis of colon cancer cells by regulating NUP37.
    Xiong H, Li Y, Liu M.
    Mol Med Rep; 2023 Jun 25; 27(6):. PubMed ID: 37203403
    [Abstract] [Full Text] [Related]

  • 39. ADORA2A promotes proliferation and inhibits apoptosis through PI3K/AKT pathway activation in colorectal carcinoma.
    Ran L, Mou X, Peng Z, Li X, Li M, Xu D, Yang Z, Sun X, Yin T.
    Sci Rep; 2023 Nov 09; 13(1):19477. PubMed ID: 37945707
    [Abstract] [Full Text] [Related]

  • 40. LncRNA ST3Gal6-AS1/ST3Gal6 axis mediates colorectal cancer progression by regulating α-2,3 sialylation via PI3K/Akt signaling.
    Hu J, Shan Y, Ma J, Pan Y, Zhou H, Jiang L, Jia L.
    Int J Cancer; 2019 Jul 15; 145(2):450-460. PubMed ID: 30613961
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.